Stonepine Capital Management, LLC Portfolio Holdings

Stonepine Capital Management, LLC

  • $103 Billion
  • Q1 2025

Stonepine Capital Management, LLC has filed its 13F form on May 14, 2025 for Q1 2025 where it was disclosed a total value porftolio of $103 Billion distributed in 66 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Ani Pharmaceuticals Inc with a value of $13.6B, Evolus, Inc. with a value of $13.6B, Optinose Inc with a value of $7.23B, Kempharm, Inc with a value of $4.87B, and Verastem Inc with a value of $3.7B.

Examining the 13F form we can see an decrease of $21.1B in the current position value, from $124B to 103B.

Stonepine Capital Management, LLC is based out at Bend, OR

Below you can find more details about Stonepine Capital Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $103 Billion
Healthcare: $76.3 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$1.11B
$13.6 Billion 13.28% of portfolio
48,000
Q1 2025 Added 135.29%
$516M
$13.6 Billion 13.28% of portfolio
1,134,574
Q1 2025 Reduced 10.29%
Optinose Inc
-
$7.23 Billion 7.04% of portfolio
-
Q1 2025 Added 33.97%
$170M
$4.87 Billion 4.74% of portfolio
650,000
Q1 2025 Added 8.75%
Verastem Inc
-
$3.7 Billion 3.6% of portfolio
-
Q1 2025 Reduced 29.54%
$307M
$3.69 Billion 3.59% of portfolio
333,400
Q1 2025 Added 2.8%
Surrozen Inc
-
$3.33 Billion 3.24% of portfolio
-
Q1 2025 Added 108.3%
$160M
$3.26 Billion 3.17% of portfolio
590,742
Q1 2025 Added 77.99%
$154M
$3.26 Billion 3.17% of portfolio
206,639
Q1 2025 Reduced 13.26%
$181M
$3.04 Billion 2.96% of portfolio
200,000
Q1 2025 Added 25.0%
$1.05B
$3.04 Billion 2.96% of portfolio
74,500
Q1 2025 Reduced 6.88%
Indivior PLC
-
$2.9 Billion 2.82% of portfolio
-
Q1 2025 Reduced 0.33%
$94M
$2.77 Billion 2.69% of portfolio
527,842
Q1 2025 Reduced 20.43%
$486M
$2.77 Billion 2.69% of portfolio
348,820
Q1 2025 Added 48.43%
$292M
$2.59 Billion 2.52% of portfolio
129,813
Q1 2025 Added 3.27%
$38.1M
$2.51 Billion 2.44% of portfolio
2,055,225
Q1 2025 Reduced 12.66%
Inhibikase Therapeutics Inc
-
$2 Billion 1.95% of portfolio
-
Q1 2025 Reduced 19.2%
$247M
$1.75 Billion 1.7% of portfolio
796,100
Q1 2025 Added 13.73%
Edesa Biotech Inc
-
$1.68 Billion 1.63% of portfolio
-
Q1 2025 New
$15.1M
$1.33 Billion 1.3% of portfolio
276,707
Q1 2025 Added 0.83%
$344M
$1.02 Billion 0.99% of portfolio
100,000
Q1 2025 New
$678M
$937 Million 0.91% of portfolio
144,628
Q1 2025 Reduced 11.87%
$107M
$914 Million 0.89% of portfolio
347,687
Q1 2025 Reduced 49.13%
Inovio Pharmaceuticals Inc
-
$845 Million 0.82% of portfolio
-
Q1 2025 Reduced 50.64%
$128M
$814 Million 0.79% of portfolio
139,942
Q1 2025 Reduced 30.03%
Aytu Biopharma Inc
-
$795 Million 0.77% of portfolio
-
Q1 2025 Added 13.78%
$521M
$795 Million 0.77% of portfolio
500,000
Q1 2025 New
$219M
$738 Million 0.72% of portfolio
212,783
Q1 2025 New
$47.9M
$687 Million 0.67% of portfolio
630,183
Q1 2025 Added 17.61%
Grace Therapeutics Inc
-
$666 Million 0.65% of portfolio
-
Q1 2025 New
$356M
$657 Million 0.64% of portfolio
110,000
Q4 2024 Added 266.67%
Calcimedica Inc
-
$615 Million 0.6% of portfolio
-
Q1 2025 Reduced 21.63%
$1.03B
$615 Million 0.6% of portfolio
20,607
Q1 2025 New
Kiora Pharmaceuticals Inc
-
$604 Million 0.59% of portfolio
-
Q1 2025 Reduced 0.16%
$193M
$581 Million 0.57% of portfolio
131,160
Q1 2025 New
$636M
$561 Million 0.55% of portfolio
102,265
Q1 2025 Reduced 43.91%
$59.1M
$501 Million 0.49% of portfolio
620,588
Q1 2025 Added 148.24%
Kezar Life Sciences Inc
-
$488 Million 0.47% of portfolio
-
Q1 2025 Reduced 9.09%
Acelyrin Inc
-
$414 Million 0.4% of portfolio
-
Q1 2025 Added 26.12%
$194M
$398 Million 0.39% of portfolio
483,647
Q1 2025 New
Septerna Inc
-
$394 Million 0.38% of portfolio
-
Q1 2025 New
$67.5M
$346 Million 0.34% of portfolio
238,950
Q1 2025 Added 80.55%
$113M
$344 Million 0.33% of portfolio
95,747
Q1 2025 Reduced 61.86%
$11.5M
$275 Million 0.27% of portfolio
278,188
Q1 2025 New
$284M
$249 Million 0.24% of portfolio
21,550
Q1 2025 New
$24.4M
$204 Million 0.2% of portfolio
508,266
Q1 2025 Reduced 27.39%
Cargo Therapeutics Inc
-
$204 Million 0.2% of portfolio
-
Q1 2025 New
$58.8M
$200 Million 0.19% of portfolio
250,000
Q1 2025 Reduced 50.0%
$3.46B
$186 Million 0.18% of portfolio
93,393
Q1 2025 Reduced 57.55%

Summary

  • Portfolio
  • No. of Stocks 66
  • Current Value $103 Billion
  • Prior Value $124 Billion
  • Filing
  • Period Q1 2025
  • Filing Date May 14, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 23 stocks
  • Additional Purchases 18 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 24 stocks
Track This Portfolio

Track Stonepine Capital Management, LLC Portfolio

Follow Stonepine Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonepine Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonepine Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email